Animal and Veterinary Innovation Centers (U18)
Food and Drug Administration
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 17, 2025
- Amount
- $1,250,000
- Closes
- May 12, 2028 (in 575 days)
Similar opportunities open now
- Vet-LIRN Capacity-Building Project and Equipment Grants (U18)Same funderOpenFood and Drug AdministrationCloses Sep 2028Up to $2.5M
- Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Jan 2028Up to $200K
- Minor Use Minor Species Development of Drugs (R01)Same funderOpenFood and Drug AdministrationCloses Jan 2027Up to $250K
- Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Sep 2028
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)Same funderOpenFood and Drug AdministrationCloses Feb 2028Up to $600K
Classification and identifiers
- Solicitation number
- PAR-24-251
- Assistance listing (CFDA)
- 93.103
Amount
$1,250,000
Who can apply
Private colleges and universities and Public colleges and universities can all apply here. Check the eligibility details below to see if your organization fits.
Higher Education Institutions:The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education: Hispanic-serving InstitutionsHistorically Black Colleges and Universities (HBCUs)Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving InstitutionsAsian American Native American Pacific Islander Serving Institutions (AANAPISIs)…
About this opportunity
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for inclusion as Animal and Veterinary Innovation Centers, which are intended to form long-term partnerships to address priority areas for FDA's Center for Veterinary Medicine (CVM). This includes CVM developing cooperative agreement(s) with academic research institutions (public and private) to: 1. Drive research that supports the development of interventions to prevent, control, or eliminate Highly Pathogenic Avian Influenza (HPAI) virus in animals, or interventions that reduce the circulation of the virus in the ecosystem. Work may also include other emerging zoonotic disease threats or One Health issues in future years. 2. Drive research that supports the development of intentional genomic alternation...